Immuneering Corp

IMRX

Company Profile

  • Business description

    Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

  • Contact

    245 Main Street
    Second Floor
    CambridgeMA02142
    USA

    T: +1 617 500-8080

    https://www.immuneering.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    54

Stocks News & Analysis

stocks

Perplexing buyback from overvalued ASX share

Earnings continue to grow but investor expectations are too high.
stocks

Most popular shares in SMSFs

With data showing the continued rise of SMSFs, we explore the top stock picks of individual investors
stocks

Will China strong arm BHP into lower iron ore prices?

Allegations that the Chinese government told steel mills to stop buying from BHP shake markets.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,208.509.00-0.10%
CAC 407,869.3864.88-0.82%
DAX 4024,171.94215.99-0.89%
Dow JONES (US)46,067.58587.981.29%
FTSE 1009,422.4620.41-0.22%
HKSE25,437.63451.85-1.75%
NASDAQ22,694.61490.182.21%
Nikkei 22546,847.321,733.12-3.57%
NZX 50 Index13,276.9974.93-0.56%
S&P 5006,654.72102.211.56%
S&P/ASX 2008,899.4010.30-0.12%
SSE Composite Index3,865.2324.27-0.62%

Market Movers